ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,734Gold OA

Cancer Biology & Therapy

Acronym:cbt
•
Abbreviation (ISO):CANCER BIOL. THER
•
Identifier (ISSN):1538-4047(Print)/1555-8576(Online)
•
Publisher:Landes Bioscience
Clarivate IF (2026)
5.7↑ +1.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Biology & Therapy

WoS Q1
24683.3720182.8820193.6620204.7420214.8820223.620234.420244.620255.72026
Annual Impact Factor Metric
Current (2026):5.7
Scopus SJR & RankScopus Q1
1.407
#2,734

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
138

138 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
51articles/year
100% Gold OA•90.16% Original Research

Aims & Scope

Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.

Topics Covered (Recognized by AI)
Biology98%Medicine96%Genetics92.5%Internal medicine85.3%Chemistry82.5%Biochemistry78.8%Cancer research78.3%Cancer67.9%Gene55.7%Cell biology38.7%Apoptosis34.3%Immunology31.6%Pathology30.4%Cell culture23.9%Oncology23.2%Surgery22.2%Cell20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank72/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank65/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.7
Articles / Year51
Total Citations3
2025
IF4.6
Articles / Year88
Total Citations339
2024
IF4.4
Articles / Year115
Total Citations1,322
2023
IF3.6
Articles / Year88
Total Citations1,228
2022
IF4.875
Articles / Year65
Total Citations1,434

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,734Scopus Q1SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.407

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.76

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,378 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,431
3-Year Documents257
Citable Documents255

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Molecular MedicineQ1
OncologyQ1
PharmacologyQ1
Cancer ResearchQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Biology & Therapy (acronym: cbt, abbr: CANCER BIOL. THER, ISSN: 1538-4047) is a peer-reviewed international scholarly journal in the field of Medicine, published by Landes Bioscience in United States since 2002. The periodical holds a Journal Impact Factor (JIF) of 5.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.407 (Q1), an H-index of 138.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 51 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,378 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Landes Bioscience
Publication Language
English
Frequency
Monthly
Founding Year
2002
Indexing & Databases
SCIEScopusPubMed
Editorial Address
LANDES BIOSCIENCE, 1002 WEST AVENUE, 2ND FLOOR, AUSTIN, USA, TX, 78701

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a213c122-ed53-4149-afc0-630a2e19f6e8
Database Updated: 2026-10-01